PharmaCielo (PharmaCielo) Accounts Payable : $0.00 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is PharmaCielo Accounts Payable?

PharmaCielo's Accounts Payable for the quarter that ended in Sep. 2023 was $0.00 Mil.

PharmaCielo Accounts Payable Historical Data

The historical data trend for PharmaCielo's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Accounts Payable Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Accounts Payable

Get a 7-Day Free Trial

2.20

PharmaCielo Quarterly Data
	Nov18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accounts Payable	Get a 7-Day Free Trial															-	-	-	-	-

PharmaCielo Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

PharmaCielo Accounts Payable Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCielo (PharmaCielo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (OTCPK:PCLOF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

PCLO:Canada

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.